These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32778537)

  • 1. The Histological Picture of Indication Biopsies in the First 2 Weeks after Kidney Transplantation.
    Van Loon E; Lerut E; Senev A; Coemans M; Pirenne J; Monbaliu D; Jochmans I; Sainz Barriga M; De Vusser K; Van Craenenbroeck AH; Sprangers B; Emonds MP; Kuypers D; Naesens M
    Clin J Am Soc Nephrol; 2020 Oct; 15(10):1484-1493. PubMed ID: 32778537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor Age Amplifies the Detrimental Effects of Cold Ischemia Time on Long-Term Kidney Allograft Survival Independently of the Occurrence of Delayed Graft Function or Early Acute Rejection.
    Rincon Cintra da Cruz P; Cabral Dias Filho A; Santana VBBM; Biela Boaretto RB; Zanettini Riccetto CL
    Exp Clin Transplant; 2020 Aug; 18(4):436-443. PubMed ID: 32552628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidneys From Deceased Elderly Donors: Factors Associated With Adverse Outcomes.
    Adekoya AO; Halawa A
    Exp Clin Transplant; 2016 Feb; 14(1):32-7. PubMed ID: 26862822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies.
    Senev A; Lerut E; Coemans M; Callemeyn J; Copley HC; Claas F; Koshy P; Kosmoliaptsis V; Kuypers D; Sprangers B; Van Craenenbroeck A; Van Loon E; Van Sandt V; Emonds MP; Naesens M
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1204-1215. PubMed ID: 35649719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
    Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):275-283. PubMed ID: 33495290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients.
    Krishnan AR; Wong G; Chapman JR; Coates PT; Russ GR; Pleass H; Russell C; He B; Lim WH
    Am J Transplant; 2016 Sep; 16(9):2714-23. PubMed ID: 27037866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies.
    Haller J; Wehmeier C; Hönger G; Hirt-Minkowski P; Gürke L; Wolff T; Steiger J; Amico P; Dickenmann M; Schaub S
    Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours.
    Hansson J; Mjörnstedt L; Lindnér P
    Clin Transplant; 2018 Sep; 32(9):e13377. PubMed ID: 30098052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes.
    Sousa MV; Zollner RL; Mazzali M
    J Bras Nefrol; 2019 Sep; 42(2):201-210. PubMed ID: 31528982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
    Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
    Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
    Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
    Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney allograft survival after acute rejection, the value of follow-up biopsies.
    El Ters M; Grande JP; Keddis MT; Rodrigo E; Chopra B; Dean PG; Stegall MD; Cosio FG
    Am J Transplant; 2013 Sep; 13(9):2334-41. PubMed ID: 23865852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
    Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Delayed Graft Function in Kidney Transplant Recipients Stratified by Histologic Biopsy Findings.
    Rolak S; Djamali A; Mandelbrot DA; Muth BL; Jorgenson MR; Zhong W; Liu P; Astor BC; Parajuli S
    Transplant Proc; 2021 Jun; 53(5):1462-1469. PubMed ID: 33579551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.